TLS/FUS Recombinant Antibody, FITC Conjugated
Product Specifications
Background
FUS/TLS (fused in sarcoma/translocated in liposarcoma) was initially identified by investigators as a component of fusion proteins found in a variety of cancers such as myxoid liposarcoma, acute myeloid leukemia, and EwingĄŻs tumor.
Synonyms
FUS; ALS6; CHOP; FUS-CHOP; FUS1; Fused in sarcoma; HnRNPP2; Oncogene TLS; ETM4; Fus-like protein; Oncogene FUS; POMP75.
Gene ID
2521
Swiss Prot
P35637
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
TLS/FUS
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human FUS
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
2521
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
037944-ML550 100 µL
LRRC19, CT (LRRC19, Leucine-rich repeat-containing protein 19) (MaxLight 550) discontinued
Ask
View Details